메뉴 건너뛰기
American Journal of Therapeutics
Volumn 15, Issue 1, 2008, Pages 82-84
A fatal case of alemtuzumab-associated interstitial pneumonitis
Author keywords

Alemtuzumab; Drug induced pneumonitis; Interstitial pneumonitis
Indexed keywords

ALEMTUZUMAB; AZITHROMYCIN; CEFTAZIDIME; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DIPHENHYDRAMINE; DOXORUBICIN; DOXYCYCLINE; FLUCONAZOLE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PARACETAMOL; PENTOSTATIN; PREDNISONE; RITUXIMAB; VALACICLOVIR; VINCRISTINE; VORICONAZOLE;
EID: 38549178601     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3181400395     Document Type: Article
Times cited : (9)
References (8)
  • 1
    • 15944377427 scopus 로고    scopus 로고
    • Alemtuzumab in the treatment of chronic lymphocytic leukemia
    • Robak T. Alemtuzumab in the treatment of chronic lymphocytic leukemia. BioDrugs. 2005;19:9-22.
    • (2005) BioDrugs , vol.19 , pp. 9-22
    • Robak, T.1
  • 2
    • 17644386490 scopus 로고    scopus 로고
    • Development of humanized antibodies as cancer therapeutics
    • Zhengxing Qu, Griffiths GL, Wegener WA, et al. Development of humanized antibodies as cancer therapeutics. Methods. 2005;36:84-95.
    • (2005) Methods , vol.36 , pp. 84-95
    • Qu, Z.1    Griffiths, G.L.2    Wegener, W.A.3
  • 3
    • 0030300084 scopus 로고    scopus 로고
    • Immunosuppressive toxicity of CAMPATH-1H monoclonal antibody in the patients with recurrent low grade lymphoma
    • Tang SC, Hewitt K, Reis MD, et al. Immunosuppressive toxicity of CAMPATH-1H monoclonal antibody in the patients with recurrent low grade lymphoma. Leuk Lymphoma. 1996;24:93-101.
    • (1996) Leuk Lymphoma , vol.24 , pp. 93-101
    • Tang, S.C.1    Hewitt, K.2    Reis, M.D.3
  • 4
    • 4944238261 scopus 로고    scopus 로고
    • Interstitial lung disease associated with drug therapy
    • Camus P, Kudoh S, Ebina M. Interstitial lung disease associated with drug therapy. Br J Cancer. 2004;91:S18-S23.
    • (2004) Br J Cancer , vol.91
    • Camus, P.1    Kudoh, S.2    Ebina, M.3
  • 5
    • 0036941305 scopus 로고    scopus 로고
    • Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: A multicenter phase I/II study
    • Uppenkamp M, Engert A, Diehl V, et al. Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study. Ann Hematol. 2002;81:26-32.
    • (2002) Ann Hematol , vol.81 , pp. 26-32
    • Uppenkamp, M.1    Engert, A.2    Diehl, V.3
  • 6
    • 0842322860 scopus 로고    scopus 로고
    • Efficacy and tolerability of alemtuzumab (CAMPATH-1H) in the salvage treatment of B-cell chronic lymphocytic leukemia: Change of regimen needed?
    • Rieger K, Von Grunhagen U, Fietz T, et al. Efficacy and tolerability of alemtuzumab (CAMPATH-1H) in the salvage treatment of B-cell chronic lymphocytic leukemia: change of regimen needed? Leuk Lymphoma. 2004;45:345-349.
    • (2004) Leuk Lymphoma , vol.45 , pp. 345-349
    • Rieger, K.1    Von Grunhagen, U.2    Fietz, T.3
  • 7
    • 33746877839 scopus 로고    scopus 로고
    • Trastuzumab (Herceptin)-associated lung injury
    • Vahid B, Mehrotra A. Trastuzumab (Herceptin)-associated lung injury. Respirology. 2006;11:655-658.
    • (2006) Respirology , vol.11 , pp. 655-658
    • Vahid, B.1    Mehrotra, A.2
  • 8
    • 0033214207 scopus 로고    scopus 로고
    • Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody
    • Winkler U, Jensen M, Manzke O, et al. Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody. Blood. 1999;94:2217-2224.
    • (1999) Blood , vol.94 , pp. 2217-2224
    • Winkler, U.1    Jensen, M.2    Manzke, O.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.